Guideline Update: Fecal Microbiota Transplantation for Recurrent C. Difficile Colitis... With Clinical Pearls

By EBMed FEATURING Paul Feuerstadt

0 views

May 22, 2024

Introduction to C. difficile Infection and Diagnostic Challenges

00:00

Misdiagnosis of Recurrence: C. difficile vs. Post-Infection IBS

05:28

Antimicrobial Therapy for C. difficile Infection

07:27

Introduction to Bezlotoxumab and Its Clinical Efficacy

11:05

Fecal Microbiota Transplantation and FDA-Approved Microbiota Restoration Therapy

14:08

Summary of Treatment Strategies for C. difficile Infection in 2024

19:15

EBMed is a nonprofit 501(c)(3) educational organization dedicated to: (1) improving GI patient care through CME education utilizing evidence-based medicine principles; and, (2) advancing the careers of women and underrepresented minorities in academic GI careers through mentorship and sponsorship opportunities.

For more information about the conference and to receive CME credit visit: https://ebmed.net/registration/

Comments 0

Login